Scientists Use Worms to Unearth Cancer Drug Targets
Embargo expired: 9-Aug-2012 10:00 AM EDT
Source Newsroom: Genetics Society of America
Newswise — BETHESDA, MD – August 9, 2012 -- Through novel experiments involving small nematode worms, scientists from Wyoming have discovered several genes that may be potential targets for drug development in the ongoing war against cancer. Specifically, researchers hypothesize that inhibiting these genes could reverse certain key traits associated with cancer cells. This discovery is published in the August 2012 issue of the Genetics Society of America’s journal GENETICS (www.genetics.org).
“Cancer is a leading cause of death worldwide,” said David S. Fay, Ph.D., a researcher involved in the work from the Molecular Biology Department at the University of Wyoming in Laramie. “We hope that by carrying out basic genetic research on one of the most widely implicated human cancer genes, that we can contribute to the arsenal of diverse therapeutic approaches used to treat and cure many types of cancer.”
To make this discovery, Dr. Fay and his colleagues used a strain of nematode worms that carried a mutation in a gene similar to one that is inactivated in many human cancers. This gene, called “LIN-35” in worms and “pRb” in humans, is thought to control at least several aspects of tumor progression including cancer cell growth and survival. The researchers systematically inactivated other individual genes in the genome of the mutant LIN-35 worms. As they deactivated various genes, scientists identified those that led to a reversal of defects caused by the loss of LIN-35, suggesting that they could be used as targets for anti-cancer therapies.
“This research is important because it offers possible new ways to shut down the genetic machinery that contributes to cancer growth and progression,” said Mark Johnston, Ph.D., Editor-in-Chief of the journal GENETICS. “The causes of cancer are complex and varied, so we must approach this disease from many angles. Using simple ‘model organisms,’ such as nematode worms to find new drug targets, is becoming an increasingly important and effective strategy.”
As a companion piece to this article, the journal GENETICS debuts a new educational resource called a Primer. The Primer article, written by Elizabeth A. De Stasio, Ph.D., of Lawrence University in Appleton, Wisconsin, provides guidelines for genetics instructors who want to use this contemporary research on nematode worms to teach their students about genetics concepts. The Primer includes background biological information on the worms, explanations of concepts used, and a sample approach to using the article in the classroom with questions for discussion. Additional Primers for instructional use will follow in future issues of GENETICS.
CITATION: S. R. G. Polley and D. S. Fay. A Network of Genes Antagonistic to the LIN-35 Retinoblastoma Protein of Caenorhabditis elegans Genetics August 2012 Volume 191, Issue 4.
GRANT SUPPORT: This work was supported by grant GM066868 from the NIH.
ABOUT GENETICS: Since 1916, GENETICS (http://www.genetics.org/) has covered high quality, original research on a range of topics bearing on inheritance, including population and evolutionary genetics, complex traits, developmental and behavioral genetics, cellular genetics, gene expression, genome integrity and transmission, and genome and systems biology. GENETICS, a peer-reviewed, peer-edited journal of the Genetics Society of America is one of the world's most cited journals in genetics and heredity.
ABOUT GSA: Founded in 1931, the Genetics Society of America (GSA) is the professional membership organization for scientific researchers, educators, bioengineers, bioinformaticians and others interested in the field of genetics. Its nearly 5,000 members work to advance knowledge in the basic mechanisms of inheritance, from the molecular to the population level. The GSA is dedicated to promoting research in genetics and to facilitating communication among geneticists worldwide through its conferences, including the biennial conference on Model Organisms to Human Biology, an interdisciplinary meeting on current and cutting edge topics in genetics research, as well as annual and biennial meetings that focus on the genetics of particular organisms, including C. elegans, Drosophila, fungi, mice, yeast, and zebrafish. GSA publishes GENETICS, a leading journal in the field and an online, open-access journal, G3: Genes|Genomes|Genetics. For more information about GSA, please visit www.genetics-gsa.org. Also follow GSA on Facebook at facebook.com/GeneticsGSA and on Twitter @GeneticsGSA.